Suppr超能文献

三种扩展焦深人工晶状体的比较评估

A comparative evaluation of three extended depth of focus intraocular lenses.

作者信息

Lesieur Gilles, Dupeyre Paul

机构信息

Centre IRIDIS, Albi, France.

出版信息

Eur J Ophthalmol. 2023 Nov;33(6):2106-2113. doi: 10.1177/11206721231154818. Epub 2023 Feb 5.

Abstract

PURPOSE

To compare the refractive and visual performance of three Extended Depth of Focus (EDOF) intraocular lenses (IOLs) after uncomplicated cataract surgery.

SETTING

Centre IRIDIS, Albi, France.

DESIGN

Comparative retrospective study.

METHODS

Patients with cataracts and without other eye diseases were enrolled for monocular implantation of EDOF IOLs on the dominated eye by the same surgeon between 2018 and 2021, using either the IsoPure (BVI-PhysIOL, Belgium), the Synthesis+ (Cutting Edge, France), or the Lucidis (SAV-IOL, Swiss). Refraction, Uncorrected Distance Visual Acuity (UDVA), Corrected Distance VA (CDVA), Uncorrected Near VA (UNVA), Distance-Corrected Near VA (DCNVA), 25% Contrast CDVA, and Defocus Curve were assessed 3-months postoperatively.

RESULTS

A total of 64 eyes of 64 patients were included in this study (IsoPure n = 22; Synthesis+ n = 20, Lucidis n = 22). CDVA, 25% Contrast CDVA and DCNVA were significantly better for Lucidis than IsoPure or Synthesis+. No significant difference was observed for CDVA and 25% Contrast CDVA between IsoPure and Synthesis+. DCNVA was significantly better for Lucidis and Synthesis+ with respectively 0.08 LogMAR ± 0,09 and 0.29 LogMAR ± 0.13, compared to 0.40 LogMAR ± 0.17 for IsoPure ( < 0.05).

CONCLUSIONS

Lucidis showed more efficient distance, low contrast, and near vision than IsoPure and Synthesis+. Synthesis+ seems to be more efficient in intermediate vision than other groups. Each EDOF IOLs provided good distance vision without creating spontaneous complaints of photic phenomena. Refractive EDOF IOLs, especially Lucidis, are efficient for patients wishing to improve their vision without dysphotopsia.

摘要

目的

比较三种扩展景深(EDOF)人工晶状体(IOL)在单纯性白内障手术后的屈光和视觉性能。

地点

法国阿尔比的IRIDIS中心。

设计

比较性回顾性研究。

方法

2018年至2021年期间,由同一位外科医生为患有白内障且无其他眼部疾病的患者在优势眼进行单眼植入EDOF IOL,使用的IOL分别为IsoPure(比利时BVI-PhysIOL公司)、Synthesis+(法国Cutting Edge公司)或Lucidis(瑞士SAV-IOL公司)。术后3个月评估屈光、未矫正远视力(UDVA)、矫正远视力(CDVA)、未矫正近视力(UNVA)、距离矫正近视力(DCNVA)、25%对比度CDVA和散焦曲线。

结果

本研究共纳入64例患者的64只眼(IsoPure组22只;Synthesis+组20只,Lucidis组22只)。Lucidis组的CDVA、25%对比度CDVA和DCNVA显著优于IsoPure组或Synthesis+组。IsoPure组和Synthesis+组之间的CDVA和25%对比度CDVA未观察到显著差异。与IsoPure组的0.40 LogMAR±0.17相比,Lucidis组和Synthesis+组的DCNVA显著更好,分别为0.08 LogMAR±0.09和0.29 LogMAR±0.13(P<0.05)。

结论

与IsoPure和Synthesis+相比,Lucidis在远视力、低对比度视力和近视力方面表现更优。Synthesis+在中间视力方面似乎比其他组更有效。每种EDOF IOL均能提供良好的远视力,且不会引发明显的光现象主诉。屈光性EDOF IOL,尤其是Lucidis,对于希望改善视力且无眩光的患者有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验